GEMTUZUMAB OZOGAMICIN for Chemotherapy: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 19 adverse event reports in the FDA FAERS database where GEMTUZUMAB OZOGAMICIN was used for Chemotherapy.
Most Reported Side Effects for GEMTUZUMAB OZOGAMICIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 412 | 22.7% | 31 | 289 |
| Pyrexia | 138 | 7.6% | 10 | 86 |
| Sepsis | 122 | 6.7% | 43 | 61 |
| Thrombocytopenia | 117 | 6.4% | 20 | 52 |
| Venoocclusive liver disease | 117 | 6.4% | 33 | 57 |
| Off label use | 88 | 4.8% | 16 | 50 |
| Drug ineffective | 87 | 4.8% | 29 | 57 |
| Death | 81 | 4.5% | 81 | 4 |
| Bone marrow failure | 80 | 4.4% | 19 | 43 |
| Neutropenia | 68 | 3.7% | 16 | 28 |
| Septic shock | 59 | 3.3% | 29 | 37 |
| Neoplasm progression | 58 | 3.2% | 31 | 14 |
| Pneumonia | 58 | 3.2% | 26 | 29 |
| Platelet count decreased | 54 | 3.0% | 9 | 21 |
| Diarrhoea | 51 | 2.8% | 7 | 44 |
Other Indications for GEMTUZUMAB OZOGAMICIN
Acute myeloid leukaemia (1,164)
Product used for unknown indication (75)
Acute myeloid leukaemia recurrent (60)
Acute myeloid leukaemia refractory (58)
Myelodysplastic syndrome (38)
Acute leukaemia (34)
Acute promyelocytic leukaemia (31)
Leukaemia recurrent (19)
Bone marrow conditioning regimen (8)
Acute myelomonocytic leukaemia (7)
Other Drugs Used for Chemotherapy
CYCLOPHOSPHAMIDE (3,372)
DOCETAXEL (2,134)
CARBOPLATIN (1,902)
DOXORUBICIN (1,756)
VINCRISTINE (1,743)
PACLITAXEL (1,425)
OXALIPLATIN (1,423)
METHOTREXATE (1,380)
CYTARABINE (1,355)
ETOPOSIDE (1,246)